WO1997020846A1 - Substituted porphyrins - Google Patents
Substituted porphyrins Download PDFInfo
- Publication number
- WO1997020846A1 WO1997020846A1 PCT/GB1996/002899 GB9602899W WO9720846A1 WO 1997020846 A1 WO1997020846 A1 WO 1997020846A1 GB 9602899 W GB9602899 W GB 9602899W WO 9720846 A1 WO9720846 A1 WO 9720846A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- optionally substituted
- alkyl
- compound
- halogen
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- XMWINMVFKPHMJB-UHFFFAOYSA-N CC1=CCCC=C1 Chemical compound CC1=CCCC=C1 XMWINMVFKPHMJB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
- C09K19/3488—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring having more than 6 members, e.g. macrocycles, phthalocyanines
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/40—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur, e.g. silicon, metals
Definitions
- Porphyrin is given by the following general formula:
- Porphyrins have found uses in numerous applications including precursors for novel conducting polymers (Wagner et al, J. Am. Chem. Soc, 1994, 116, 9759; Anderson, Inorg. Chem., 1994, 33, 972 and Arnold et al, Tetrahedron, 1992, 48, 8781); non- linear optically active (NLO) materials (Anderson et al, Angew. Chem. Int. Ed. Engl., 1994, 33, 655 and Arnold et al, J. Am. Chem. Soc, 1993, 115, 12197); photosynthetic m ⁇ del compounds (Wagner et al, J. Org. Chem., 1995, 60, 5266.
- NLO non- linear optically active
- R 1 , R 2 , R 3 and R 4 are each independently H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl) 3 , halogen, CHO, OH, CN, NO 2 , NO, NR 5 R 6 or the following Formula II:
- R 5 and R 6 are each independently hydrogen, optionally subsituted alkyl, optionally substituted alkenyl, optionally substituted aryl, halogen or hydroxy;
- X, Y, X 1 , Y 2 and Z are each independently H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl) 3 , halogen, CHO, OH, CN, NO 2 , NO, NR 5 R 6 , any adjacent two groups taken together form a -(OCH 2 CH 2 ) n - group wherein n is 1 , 2 or 3, or the following Formula III: wherein J is a single bond, ⁇ , CH 2 O, OCH 2 , COO, OOC, NHCO, CONH, CH 2 or O;
- Q is H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl) 3 , halogen, CHO, OH, CN, NO 2 , NO, NR 5 R 6 ; is optionally substituted aryl or optionally subsituted heteroaryl;
- R 1 , R 2 , R 3 or R 4 is selected from Formula II;
- M is 2H with each of the two nitrogen atoms indicated being bonded to a single hydrogen, or M is a metal atom, metal compound or silicon or a compound of silicon.
- the metal atom may be present for example as the metal with an oxidation state of +2 or it may be present with other ligands (or anions) attached to it. These ligands (anions) may serve the purpose of altering the hydrophobicity of the molecule as a whole.
- suitable anions include bromine, chlorine or oxide.
- suitable metals include Ni, Pb, V, Pd, Co, Nb, Al, Sn, Zn, Cu, Mg, Ca, In, Ga, Fe, Eu, Lu, Pt, Ru, Mn and Ge.
- Compounds of general Formula I may also be protonated so that they carry a +1 or +2 charge.
- R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X 1 , Y 2 , X, Y or Q is alkyl, or contains an alkyl moiety, it can be straight or branched chain and is preferably C 1-20 alkyl.
- R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are more preferably C 1-6 alkyl, even more preferably C 1-4 alkyl, for example methyl, ethyl, propyl, iso-propyl, n-butyl, isobutyl, sec-butyl or t-butyl.
- Z, X 1 , Y 2 , X, Y or Q are more preferably C 7-20 alkyl for example, -C 7 H 15 -, -C 8 H 17 , -C 9 H 19 , -C 10 H 21 , -C 11 H 23 , -C 12 H 25 , -C 13 H 27 .
- R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X 1 , Y 2 , X, Y or Q may comprise one or more
- substitutents chosen from halogen, NO 2 , CN, -COOR 5 or a salt thereof, hydroxy or alkoxy.
- R 1 , R 2 , R 3 , R 4 , Z, X 1 , Y 2 , X, Y or Q is a subsituted alkenyl group, or contains an alkenyl moiety, it may be straight or branched chain and is preferably C 2-20 alkenyl.
- R 1 to R 6 are more preferably C 2-6 , even more preferably C 2-4 alkenyl, for example vinyl, but-3-enyl or 3-methyl-but-3-enyl.
- Z, X 1 , Y 2 , X, Y or Q are more preferably C 7-20 alkenyl.
- R 1 , R 2 , R 3 , R 4 , Z, X 1 , Y 2 , X, Y or Q is a subsituted alkenyl group, or contains a substituted alkenyl moiety, it may comprise one or more substituents chosen from halogen, -COOR 5 or a salt thereof, hydroxy, NO 2 and CN.
- R 1 , R 2 , R 3 , R 4 , Z, X 1 , Y 2 , X, Y or Q is an optionally subsituted alkoxy or alkenyloxy group, or contains a subsituted alkoxy or alkenyloxy moiety, it may be straight or branched chain and is preferably C 1-20 alkoxy or alkenyloxy.
- R, to R 6 are more preferably C 1-6 alkoxy or alkenyloxy.
- Z, X, Y, X 1 , Y 2 or Q are more preferably C 7-20 alkoxy alkenyloxy.
- R 1 , R 2 , R 3 , R 4 , Z, X 1 , Y 2 , X, Y or Q is the group COOR 5 , it is preferably COOH; an alkoxycarbonyl group, for example methoxycarbonyl and ethoxycarbonyl; or a haloalkenyloxycarbonyl group, for example 3,4,4-trifluorobut-3-enyloxycarbonyl, 3-methyl-4,4-difluorobut-3-enyloxycarbonyl.
- a or B is aryl, or contains an aryl moiety, it is preferably C 6-10 aryl, more preferably it is phenyl.
- a or B is heteroaryl, or contains a heteroaryl moiety, it is preferably a 5 or 6 membered ring contaiing at least O, N or S atom as the heteroatom, for example pyridine, pyrrole, pyrazine, imidazole, furan or thiophene.
- a or B is subsituted aryl or heteroaryl it may comprise one or more substituents chosen from alkyl, alkoxy, haloalkyl, halogen, COOR 5 or a salt thereof, CN or NO 2 .
- Examples of these groups are 4-methylphenyl, 4-chIorophenyl, 4- fluorophenyl, 4-nitrophenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 4- chlorobenzyl, 4-fluorobenzyl, 3-trifluoromethylbenzyl, 4-trifluoromethylbenzyl, 4- nitrobenzyl and 4-methylbenzyl.
- R 1 , R 2 , R 3 , R,, R 5 , R 6 , Z, X 1 , Y 2 , X, Y or Q is halogen, or contains a halogen moiety, it is preferably fluorine, chlorine, bromine or iodine. Even more preferably, it is fluorine, chlorine or bromine.
- R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X 1 , Y 2 , X, Y or Q is a haloalkyl or haloalkenyl group it may contain one or more halogen atoms, preferably chlorine, fluorine or bromine.
- Examples of these groups are fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 2,2-difluoroethyl, 3,3-dichloroprop-2-enyl, 2-chloroprop-2-enyl, 3,4,4-trifluorobut-3-enyl, 4-fluorobut-3-enyl, 4,4-difluorobut-3-enyl and 3-methyl-4,4-difluorobut-3-enyl.
- any one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X 1 , Y 2 , X, Y or Q is a haloalkoxy group it may contain one or more halogen atoms, preferably chlorine, fluorine or bromine.
- R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X 1 , Y 2 , X, Y or Q is -NR 5 R 6 it is preferably NH 2 ; a mono-alkylamino group, for example methylamino or ethylamino; or a di-alkylamino group, for example dimethylamino or diemylamino.
- R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X 1 , Y 2 , X, Y or Q is Si(alkyl) 3 it is preferably Si(C 1-6 alkyl), for example trimethylsilyl, triethylsilyl or triisopropylsilyl.
- R 1 , R 2 , R 3 , and R 4 are all a group of Formula II.
- R 1 and R 3 are a group of Formula II and R 2 and R 4 are H or Si(CH 3 ) 3 , or R 2 and R 4 are a group of Formula II and R 1 and R 3 are H or Si(CH 3 ) 3 .
- M is 2H or Zn.
- M is a silicon compound it is Si-alkoxy or Si-OH.
- any one of X, Z or Y is C 1-20 alkyl or alkoxy.
- X and Z or Y and Z together form a - (OCH 2 CH 2 ) n - group.
- Porphyrins usually have a characteristic red colour due to an intense absorption (called the B band: a pi-pi* transition) in the region 400-420nm.
- the B band a pi-pi* transition
- Q bands weaker absorptions
- M 2H, 4 bands
- M 4H, 2 bands
- M M, 2 bands
- the compounds of the present invention may be used in a broad range of applications including those applications mentioned in the introduction of this application.
- Other uses include pigments or dyes, as components of discotic liquid crystal phases (in particular they may also be used a precursors for discotic liquid crystals), two dimensional conjugated polymeric arrays, see Drain and Lehn, J. Chem. Soc, Chem. Commun., 1994, 2313: as reverse saturable absorbers and as agents for photodynamic therapy.
- the types of liquid crystal devices include linear and non-linear electrical, optical and electro-optical devices, magneto-optical devices and devices providing responses to stimuli such as temperature changes and total or partial pressure changes.
- the compounds of the present invention may also be used in biaxial nematic devices and as second or third order non-linear optic (NLO) materials.
- NLO non-linear optic
- Z' is an electron donating group such as alkyl, alkoxy, for example C 1-15 , dialkylamine or diarylamine and Z" is an electron withdrawing group such as NO 2 , CN, halogen, NO, NH 2 , an ester or carboxylic acid may be useful as biaxial nematic liquid crystal materials possessing NLO properties.
- Z" is an electron withdrawing group and Z' is an electron donating group, then the materials below may be of use as second and/or third order NLO materials.
- Ga x Al 1-x As lasers where x is from 0 to 1, and is preferably 1, has proven popular in the above applications because they can provide laser energy at a range of
- Gallium arsenide lasers provide laser light at wavelengths of about 850nm, and are useful for the above applications. With increasing Al content (x ⁇ 1), the laser wavelength may be reduced down to about 750nm. The storage density an be increased by using a laser of shorter wavelength.
- the compounds of the present invention may be suitable as optical storage media and may be combined with dyes for use in laser addressed systems, for example in optical recording media.
- the porphyrin will absorb in the near-infrared.
- the near-infrared absorber may be coated or vacuum-deposited onto a transparent substrate.
- EP 0 337 209 A2 describes the processes by which the above optical-recording media may be made.
- the compounds of the present invention are useful in near- infrared absorption filters and liquid crystal display devices. As described similarly in EP 0
- display materials can be made by mixing a near-infrared absorber of Formula I with liquid crystal materials such as nematic liquid crystals, smectic liquid crystals and cholesteric liquid crystals.
- liquid crystal materials such as nematic liquid crystals, smectic liquid crystals and cholesteric liquid crystals.
- the compounds of the present invention may be incorporated into liquid crystal panels wherein the near infrared-absorber is incorporated with the liquid crystal and a laser beam is used to write an image.
- Another preferred compound is 10,20-mesobis(arylethynyl)porphyrin as a calamitic mesogen.
- Langmuir Blodgett films incorporating porphyrins of the present invention may be laid down using conventional and well known techniques, see R.H. Tredgold in "Order in Thin Organic Films", Cambridge University Press, p74, 1994 and reference therein.
- Polymerised porphyrins may also be used in, for example, Langmuir Blodgett films.
- the porphyrin may be incorporated into a polymer.
- Polymerisation may be effected by one or more of the positions R 1 -R 4 in Formula I for example via one or more of the OH groups or via the central metal atom or metal compound or polymerisation may be achieved by a combination of the above techniques.
- An example of a suitable substituent which may be used to effect polymerisation is an unsaturated substituent such as an alkene group.
- An example of a repeating unit of one such polymer is shown below:
- Main chain or side chain liquid crystal polymers may also be made using the compounds of the present invention or metal-metal linked liquid crystal polymers.
- We have synthesised unsymmetrical chlorphyrins, i.e. , with one type of arylethynyl moiety in the 5- and 15-meso-positions and a different arylethynyl moiety in the 10- and 20-positions. Examples are shown below (where Z'" alkyl):
- porphyrins with two bare acetylenes. These can be polymerised or copolymerised (e.g.. with poly(phenylene vinylene)) to make electroluminescent polymers. Alternatively, the bare acetylenic substituents may be reacted individually with electron donor and acceptor groups to furnish "push-pull" acetylenic porphyrins with large 1st-order hyperpolarisabilities.
- protecting groups e.g. Me 3 Si-
- Langmuir Blodgett Films incorporating compounds of the present invention may be used as optical or thermally addressable storage media.
- the compounds of the present invention may also be used as molecular wires, see R.J.M. Nolte at al, Angew. Chem. Int. Ed. Eng., 1994, 33(21), 2173.
- Water soluble paramagnetic manganese complexes of the porphyrins of the present invention may be used in methods for enhancing images obtained from magnetic resonance imaging of a region of regions containing a malignant tumour growth.
- the compounds of the present invention may be used as photodynamic therapeutic (PDT) agents.
- PDT photodynamic therapeutic
- the combination of a sensitiser and electromagnetic radiation for the treatment of cancer is commonly known as photodynamic therapy.
- dye compounds are administered to a tumour-bearing subject, these dye substances may be taken up, to a certain extent by the tumour.
- an appropriate light source e.g. a laser
- the tumour tissue is destroyed via the dye mediated photo-generation of a species such as singlet oxygen or other cytotoxic species such as free radicals, for example hydroxy or superoxide.
- a species such as singlet oxygen or other cytotoxic species such as free radicals, for example hydroxy or superoxide.
- Porphyrins absorb strongly in the blue, which means they are not well “tuned” to work with red light and so their PDT effect is not very penetrating.
- macrocycles with intense, longer- wave absorptions e.g., chlorins, phthalocyanines,
- Chlorphyrins have better red-light absorbing properties than porphyrins, and would be well-suited for PDT. Further, chlorphyrins showing excellent triplet-state yields and lifetimes.
- PCT/GB94/01847 describes substituted metallophthalocyanines and phthalocyanines as PDT agents. Many of the techniques described therein (and references cited) are applicable to the current materials.
- Metalloporphyrins particularly the Pt and Pd complexes, have been used in phosphoimmunoassays (PLA) [AP Savitsby et al, Dokl. Acad. Nauk SSSR, 1989, 304, 1005]. Also the extreme sensitivity of these metalloporphyrins' triplet excited states to dissolved oxygen has been used to measure dissolved O 2 levels in biological systems [TJ Green et al, Anal. Biochem. , 1988, 174, 73; EP 0 127 797A and US-A- 4,707,454]. Because porphyrins subsituted with four mw ⁇ arylethynyl groups have very high triplet yields, we envisage they will have improved characteristics of PLA and/or sensitivity to dissolved O 2 .
- the compound of Formula contains at least one crown-ether.
- a preferred example is shown below:
- chlorphyrins with aryl crown-ether substituents will complex suitable metal cations. This will be efficiently 'communicated' to the macrocycle, via the acetylenic groups. Such a substituted chlorphyrin will experience significant alteration of the absorption and/or emission properties.
- NLO-active unsymmetrical chlorphyrins with two crown-ether substituents may change their NLO properties on metal complexation.
- crown-ether-substituted chlorphyrins could act as sensors for low concentrations of metals.
- Figure 6 illustrates a liquid crystal device in which the materials of the current invention may be incorporated.
- Reagents and conditions used in the synthetic routes of Figures 1 and 2 are as follows: i) BuLi/THF/-78°C
- Reagents and conditions used in the synthetic route of Figure 4 are as follows:
- Butyllithium was ordered as a 1.6 molar solution in THF from Aldrich Chemical Co.
- K 2 CO 3 anhydrous potassium carbonate
- 4-Octylphenylpropynal 3 was prepared from 4-octylphenylactetylene by quenching the acetylide (formed by low temperature reaction with BuLi. see Brandsma in "Preparative Acetylene Chemistry” 2nd Edition, Studies in Organic Chemistry 34, Elsevier Science Publishers (Amsterdam), 1998, Chapter 2, pl3) with DMF, followed by acid hydrolysis.
- 4-Nonyloxyphenylpropanal 5 was prepared in a three-step synthesis from 4- hydroxybenzaidehyde. Alkylation of the phenolic -OH with 1 -bromononane was followed by a Corey and Fuchs reaction with CBr 4 , triphenylphosphine and zinc (see Tetrahedron Lett.. 1972, 3769) to give ⁇ , ⁇ -dibromostyryl derivative 4. Low temperature reaction of 4 with 2.5 equivalents of BuLi followed by quenching of the acetylide with DMF and acid hydrolysis yielded 5 Care was taken not to allow the acidity of this reaction to drop below pH 6-7 otherwise no arylpropynal was produced
- porphyrin 2c in 3% yield.
- a second porphyrin- like product was separated as the major product via column chromatography on silica gel, eluting with DCM.
- Alkynyl meso substituents significantly red-shift the porphyrin B and Q bands (see Anderson, Tetrahedron Lett., 1992, 33, 1 101). Thus, compared to
- the B band of porphyrin 1 (shown below) is red-shifted by about 34nm. Replacing the trimethylsilyl group of 1 with an aryl group increases the B and Q band red shifts even further (46 ⁇ 2a ⁇ , 54 ⁇ 2b ⁇ , and 57 ⁇ 2c ⁇ nm for the B band). In addition, there is a marked increase in the main Q band absorption relative to that of the B band, and two of the Q bands appear as smaller shoulders either side of the main Q band absorption.
- porphyrin-like by-products may be isomers of 2b and 2c - containing 2-aza-21 -carbaporphyrin macrocycle as described by Chmielewskj at al, Chem. Eur. J., 1995, 1, 68.
- trans-disubstituted meso-tetraethynylporphyrins in accordance with the present invention may be prepared by coupling acetylenic dipyrromethanes with substituted propynals.
- the synthesis involves reaction of arylethynyl dipyrromethanes with a variety of propynals.
- arylethynyl dipyrromethanes were prepared in high yield via Lindsey' s procedure.
- Chlorphyrins were synthesised by condensation of propynals prepared using literature methods with arylethynyl dipyrromethanes at -25oC in the presence of BF 3 .OEt 2 as catalyst. DDQ oxidation of the resulting porphyrinogens gave high yields of chlorphyrins.
- a preferred variation on this process involves protection of the acteylene moiety in the acetylene-aldehyde precursor with dicobaltoctacarbonyl. Following the preparation of the porphyrin. either by one-pot Lindsey synthesis or via the dipyrromethane, the protecting group is photochemically removed to afford the mejotetraarylethynylporphyrin in much improved yield.
- A is phenyl are given below in Tables I and II; although A could just as easily be for example pyridine, pyrrole, pyrazine, imidazole, furan or thiophene.
- the Liquid crystal device consists of two transparent plates, 1 and 2, for example made from glass. These plates are coated on their internal face with transparent conducting electrodes 3 and 4. An alignment layer is introduced onto the internal faces of the cell so that a planar orientation of the molecules making up the liquid crystalline material will be approximately parallel to the glass plates 1 and 2. This is done by coating the glass plates 1,2 complete with conducting electrodes 3,4 with layers of film 5 and 6 of a suitable polymer, e.g. polyimide.
- the electrodes 3,4 may be formed into row and column electrodes so that the intersections between each column and row form an x,y matrix of addressable elements or pixels.
- the films 5,6 Prior to the construction of the cell the films 5,6 are rubbed with a roller covered in cloth (for example made from velvet) in a given direction, the rubbing directions being arranged parallel (same or opposite direction) upon construction of the cell.
- Liquid crystal material 8 is introduced between glass plates 1,2 by filling the space in between them. This may be done by flow filling the cell using the standard techniques.
- the spacer 7 is sealed with an adhesive 9 in a vacuum using an existing technique.
- Polarisers 10, 11 may be arranged in front of and behind the cell.
- Alignment layers may be introduced onto one or more cell walls by one or more of the standard surface treatment techniques such as rubbing, oblique evaporation or as described above by the use of polymer aligning layers.
- the device may operate in a transmissive or reflective mode.
- a transmissive or reflective mode In the former, light passing through the device, e.g. from a tungsten bulb, is selectively transmitted or blocked to form the desired display.
- a mirror, or diffuse reflector 12 In the reflective mode a mirror, or diffuse reflector 12 is placed behind the second polariser 11 to reflect ambient light back through the cell and two polarisers. By making the mirror partly reflecting the device may be operated both in a transmissive and reflective mode.
- a single polariser and dye material may be combined.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A compound of general formula (I) wherein R1, R2, R3 and R4 are each independently H, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted alkenyl, optionally substituted alkenyloxy, Si(alkyl)3, halogen, CHO, COOR5, OH, CN, NO2, NO, NR5R6 or formula (II) wherein (A) is optionally substituted aryl or optionally substituted heteroaryl; R5 and R6 are each independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, halogen or hydroxy; X, Y, X1, Y2 and Z are each independently H, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted alkenyl, optionally substituted alkenyloxy, Si(alkyl)3, halogen, CHO, COOR5, OH, CN, NO2, NO, NR5R6, any adjacent two groups taken together form a-(OCH2CH2)n-group wherein n is 1, 2 or 3, or formula (III) wherein J is a single bond, , CH2O, OCH2, COO, OOC, NHCO, CONH, CH2 or O; Q is H, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted alkenyl, optionally substituted alkenyloxy, Si(alkyl)3, halogen, CHO, COOR5, OH, CN, NO2, NO, NR5R6; (B) is optionally substituted aryl or optionally substituted heteroaryl; provided that at least one of R1, R2, R3 or R4 is selected from formula (II); M is 2H with each of the two nitrogen atoms indicated being bonded to a single hydrogen, or M is a metal atom, metal compound or silicon or a compound of silicon and its uses, particularly in a liquid crystal device, as a reverse saturable absorber, a photodynamic therapy agent and in a biaxial nematic device.
Description
SUBSTITUTED PORPHYRINS
This invention relates to novel substituted porphyrin compounds and their uses. Porphyrin is given by the following general formula:
Porphyrins have found uses in numerous applications including precursors for novel conducting polymers (Wagner et al, J. Am. Chem. Soc, 1994, 116, 9759; Anderson, Inorg. Chem., 1994, 33, 972 and Arnold et al, Tetrahedron, 1992, 48, 8781); non- linear optically active (NLO) materials (Anderson et al, Angew. Chem. Int. Ed. Engl., 1994, 33, 655 and Arnold et al, J. Am. Chem. Soc, 1993, 115, 12197); photosynthetic m∏del compounds (Wagner et al, J. Org. Chem., 1995, 60, 5266. and Lin et al, Science, 1994, 264. 1105); and enzyme mimics (Anderson et al, Angew. Chem. Int. Ed. Engl, 1990, 29, 1400; Anderson et al, J. Chem. Soc, Chem. Commun., 1992, 946 and Mackay et al, J. Chem. Soc, Chem. Commun., 1992, 43). Meso-tetraalkynyl-substituted porphyrins are reported by Anderson in Tetrahedron Lett., 1992, 33 1101. There exists a need for improved compounds which may be used in any of the above applications as well as other applications.
According to the present invention compounds of the following Formula I are provided:
wherein R1, R2, R3 and R4 are each independently H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl)3, halogen, CHO, OH, CN, NO2, NO, NR5R6 or the following Formula II:
R5 and R6 are each independently hydrogen, optionally subsituted alkyl, optionally substituted alkenyl, optionally substituted aryl, halogen or hydroxy;
X, Y, X1, Y2 and Z are each independently H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl)3, halogen, CHO, OH, CN, NO2, NO, NR5R6, any adjacent two groups taken together form a -(OCH2CH2)n- group wherein n is 1 , 2 or 3, or the following Formula III:
wherein J is a single bond,≡ , CH2O, OCH2, COO, OOC, NHCO, CONH, CH2 or O;
Q is H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl)3, halogen, CHO, OH, CN, NO2, NO, NR5R6;
is optionally substituted aryl or optionally subsituted heteroaryl;
provided that at least one of R1, R2, R3 or R4 is selected from Formula II;
M is 2H with each of the two nitrogen atoms indicated being bonded to a single hydrogen, or M is a metal atom, metal compound or silicon or a compound of silicon.
The metal atom may be present for example as the metal with an oxidation state of +2 or it may be present with other ligands (or anions) attached to it. These ligands (anions) may serve the purpose of altering the hydrophobicity of the molecule as a whole. Examples of suitable anions include bromine, chlorine or oxide. Examples of suitable metals include Ni, Pb, V, Pd, Co, Nb, Al, Sn, Zn, Cu, Mg, Ca, In, Ga, Fe, Eu, Lu, Pt, Ru, Mn and Ge. Compounds of general Formula I may also be protonated so that they carry a +1 or +2 charge.
When any one or more of R,, R2, R3, R4, R5, R6, Z, X1, Y2, X, Y or Q is alkyl, or contains an alkyl moiety, it can be straight or branched chain and is preferably C1-20 alkyl. R1, R2, R3, R4, R5 and R6 are more preferably C1-6 alkyl, even more preferably C1-4 alkyl, for example methyl, ethyl, propyl, iso-propyl, n-butyl, isobutyl, sec-butyl
or t-butyl. Z, X1, Y2, X, Y or Q are more preferably C7-20 alkyl for example, -C7H15-, -C8H17, -C9H19, -C10H21, -C11H23, -C12H25, -C13H27.
When any one of R1, R2, R3, R4, R5, R6, Z, X1, Y2, X, Y or Q is a subsituted alkyl group, or contains a substituted alkyl moiety, it may comprise one or more
substitutents chosen from halogen, NO2, CN, -COOR5 or a salt thereof, hydroxy or alkoxy.
When any one of R1, R2, R3, R4, Z, X1, Y2, X, Y or Q is a subsituted alkenyl group, or contains an alkenyl moiety, it may be straight or branched chain and is preferably C2-20 alkenyl. R1 to R6 are more preferably C2-6, even more preferably C2-4 alkenyl, for example vinyl, but-3-enyl or 3-methyl-but-3-enyl. Z, X1, Y2, X, Y or Q are more preferably C7-20 alkenyl. When any one of R1, R2, R3, R4, Z, X1, Y2, X, Y or Q is a subsituted alkenyl group, or contains a substituted alkenyl moiety, it may comprise one or more substituents chosen from halogen, -COOR5 or a salt thereof, hydroxy, NO2 and CN.
When any one of R1, R2, R3, R4, Z, X1, Y2, X, Y or Q is an optionally subsituted alkoxy or alkenyloxy group, or contains a subsituted alkoxy or alkenyloxy moiety, it may be straight or branched chain and is preferably C1-20 alkoxy or alkenyloxy. R, to R6 are more preferably C1-6 alkoxy or alkenyloxy. Z, X, Y, X1, Y2 or Q are more preferably C7-20 alkoxy alkenyloxy. When any one of R1, R2, R3, R4, Z, X1, Y2, X, Y or Q is the group COOR5, it is preferably COOH; an alkoxycarbonyl group, for example methoxycarbonyl and ethoxycarbonyl; or a haloalkenyloxycarbonyl group, for example 3,4,4-trifluorobut-3-enyloxycarbonyl, 3-methyl-4,4-difluorobut-3-enyloxycarbonyl. When A or B is aryl, or contains an aryl moiety, it is preferably C6-10 aryl, more preferably it is phenyl.
When A or B is heteroaryl, or contains a heteroaryl moiety, it is preferably a 5 or 6 membered ring contaiing at least O, N or S atom as the heteroatom, for example pyridine, pyrrole, pyrazine, imidazole, furan or thiophene. When A or B is subsituted aryl or heteroaryl it may comprise one or more substituents chosen from alkyl, alkoxy, haloalkyl, halogen, COOR5 or a salt thereof, CN or NO2. Examples of these groups are 4-methylphenyl, 4-chIorophenyl, 4- fluorophenyl, 4-nitrophenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 4- chlorobenzyl, 4-fluorobenzyl, 3-trifluoromethylbenzyl, 4-trifluoromethylbenzyl, 4- nitrobenzyl and 4-methylbenzyl.
When any one of R1, R2, R3, R,, R5, R6, Z, X1, Y2, X, Y or Q is halogen, or contains a halogen moiety, it is preferably fluorine, chlorine, bromine or iodine. Even more preferably, it is fluorine, chlorine or bromine.
Thus when any one of R1, R2, R3, R4, R5, R6, Z, X1, Y2, X, Y or Q is a haloalkyl or haloalkenyl group it may contain one or more halogen atoms, preferably chlorine, fluorine or bromine. Examples of these groups are fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 2,2-difluoroethyl, 3,3-dichloroprop-2-enyl, 2-chloroprop-2-enyl, 3,4,4-trifluorobut-3-enyl, 4-fluorobut-3-enyl, 4,4-difluorobut-3-enyl and 3-methyl-4,4-difluorobut-3-enyl.
Similarly when any one of R1, R2, R3, R4, R5, R6, Z, X1, Y2, X, Y or Q is a haloalkoxy group it may contain one or more halogen atoms, preferably chlorine, fluorine or bromine.
When any one of R1, R2, R3, R4, R5, R6, Z, X1, Y2, X, Y or Q is -NR5R6 it is preferably NH2; a mono-alkylamino group, for example methylamino or ethylamino; or a di-alkylamino group, for example dimethylamino or diemylamino.
When any one of R1, R2, R3, R4, R5, R6, Z, X1, Y2, X, Y or Q is Si(alkyl)3 it is preferably Si(C1-6 alkyl), for example trimethylsilyl, triethylsilyl or triisopropylsilyl.
Preferably R1, R2, R3, and R4 are all a group of Formula II.
Preferably R1 and R3 are a group of Formula II and R2 and R4 are H or Si(CH3)3, or R2 and R4 are a group of Formula II and R1 and R3 are H or Si(CH3)3.
Preferably M is 2H or Zn.
Preferably when M is a silicon compound it is Si-alkoxy or Si-OH.
Preferably any one of X, Z or Y is C1-20 alkyl or alkoxy. Preferably X and Z or Y and Z together form a - (OCH2CH2)n- group.
Porphyrins usually have a characteristic red colour due to an intense absorption (called the B band: a pi-pi* transition) in the region 400-420nm. In the visible part of the spectrum, there are weaker absorptions (called Q bands) in the region 500-650nm, the number depending on whether the macrocycle is in the form of a free-base (M =2H, 4 bands), a dication (M = 4H, 2 bands) or a metal complex (M = M, 2 bands). As described below in greater detail, one advantage of the effect of meso¬arylethynyl groups is to extensively red-shift the whole UV/visible spectrum by as much as 50 nm. The intensity of the Q bands is also increased relative to the B band. This turns the characteristic porphyrin red colour to a brilliant green: hence the trivial name, chlorphyrin - green porphyrin.
The compounds of the present invention may be used in a broad range of applications including those applications mentioned in the introduction of this application. Other uses include pigments or dyes, as components of discotic liquid crystal phases (in particular they may also be used a precursors for discotic liquid crystals), two dimensional conjugated polymeric arrays, see Drain and Lehn, J. Chem. Soc, Chem.
Commun., 1994, 2313: as reverse saturable absorbers and as agents for photodynamic therapy. The types of liquid crystal devices include linear and non-linear electrical, optical and electro-optical devices, magneto-optical devices and devices providing responses to stimuli such as temperature changes and total or partial pressure changes.
The compounds of the present invention may also be used in biaxial nematic devices and as second or third order non-linear optic (NLO) materials.
The materials illustrated below when Z' is an electron donating group such as alkyl, alkoxy, for example C1-15, dialkylamine or diarylamine and Z" is an electron withdrawing group such as NO2, CN, halogen, NO, NH2, an ester or carboxylic acid may be useful as biaxial nematic liquid crystal materials possessing NLO properties. Partciularly when Z" is an electron withdrawing group and Z' is an electron donating group, then the materials below may be of use as second and/or third order NLO materials.
Examination of the UV/visible data in Table 1 shows that 4-alkoxyaryl groups red-shift the spectra of chlorphyrins far more than in the equivalent
mesotetraarylporphyrins. Clearly, the acetylenic groups vastly improve
"communication" between aryl substituents and the macrocycle. This electronic coupling of macrocycle, acetylenic groups and aryl substituents may provide, at least in symmetric molecules, materials with large 2nd order hyperpolarisabilities.
Compounds of the present invention may also be liquid crystalline materials with
NLO properties.
Materials have been proposed for laser addressed applications in which laser beams are used to scan across the surface of the material or leave a written impression thereon. For various reasons many of these materials have consisted of organic materials which are at least partially transparent in the visible region. The technique relies upon localised absorption of laser energy which causes localised heating and in turn alters the optical properties of the otherwise transparent material in the region of contact with the laser beam. Thus as the beam traverses the material, a written impression of its path is left behind. One of the most important of these applications is in laser addressed optical storage devices, and in laser addressed projection displays in which light is directed through a cell containing the material and is projected onto a screen. Such devices have been described by Khan, Appl. Phys. Lett., 1973, 22, 111; and by Harold and Steele in Proceedings of Euro display, 84, 29-31 , September 1984, Paris, France, in which the material in the device was a smectic liquid crystal material. Devices which use a liquid crystal material as the optical storage medium are an important class of such devices. The use of semiconductor lasers, especially
GaxAl1-xAs lasers where x is from 0 to 1, and is preferably 1, has proven popular in the above applications because they can provide laser energy at a range of
wavelengths in the near infra-red which cannot be seen and thus cannot interfere with the visual display, and yet can provide a useful source of well-defined, intense heat energy. Gallium arsenide lasers provide laser light at wavelengths of about 850nm, and are useful for the above applications. With increasing Al content (x<1), the laser wavelength may be reduced down to about 750nm. The storage density an be increased by using a laser of shorter wavelength.
The compounds of the present invention may be suitable as optical storage media and may be combined with dyes for use in laser addressed systems, for example in optical recording media. Typically the porphyrin will absorb in the near-infrared. In order to make an optical recording media using a near-infrared absorber, the near-infrared absorber may be coated or vacuum-deposited onto a transparent substrate. EP 0 337
209 A2 describes the processes by which the above optical-recording media may be made. Further, the compounds of the present invention are useful in near- infrared absorption filters and liquid crystal display devices. As described similarly in EP 0
337 209 A2, display materials can be made by mixing a near-infrared absorber of Formula I with liquid crystal materials such as nematic liquid crystals, smectic liquid crystals and cholesteric liquid crystals. The compounds of the present invention may be incorporated into liquid crystal panels wherein the near infrared-absorber is incorporated with the liquid crystal and a laser beam is used to write an image.
Mixtures of porphyrins of the current invention may be mixed with liquid crystal materials in order to be used in guest-host systems. GB 2,229,190 B describes the use of phthalocyanines incorporated into liquid crystal materials and their subsequent use in electro-optical devices.
Previously meso-substituted porphyrins have not been seriously exploited as potential mesogens.
The phenyl ring is an excellent platform for appending mesogenic groups (e.g., X, Y or Z = alkyl or alkoxy) but in mwotetraarylporphyrins, it is approximately orthogonal to the plane of the porphyrin macrocycle. It is believed that separating the phenyl ring from the macrocycle, via an acetylenic link, would allow it to become coplanar with the macrocycle to provide a discotic mesogen. Preferably long alkoxy chains are placed in the aryl 3- and 5-positions to provide a discotic mesogen.
Preliminary investigations of compounds where a group of Formula II (where Z= OC10H21 and X, Y, X1, Y2 = H) are in the four meso positions reveal that it has a classic columnar discotic phase (probably Dh symmetry) with a discotic range from 110-230°C. The following two compounds where X', Y' and Z' are alkyl also show a columnar discotic phase.
Another preferred compound is 10,20-mesobis(arylethynyl)porphyrin as a calamitic mesogen.
Langmuir Blodgett films incorporating porphyrins of the present invention may be laid down using conventional and well known techniques, see R.H. Tredgold in "Order in Thin Organic Films", Cambridge University Press, p74, 1994 and reference therein.
It may be advantageous to polymerise certain of the compounds described by the current invention. Polymerised porphyrins may also be used in, for example, Langmuir Blodgett films. There are numerous ways in which the porphyrin may be incorporated into a polymer. Polymerisation may be effected by one or more of the positions R1-R4 in Formula I for example via one or more of the OH groups or via the central metal atom or metal compound or polymerisation may be achieved by a combination of the above techniques. An example of a suitable substituent which may be used to effect polymerisation is an unsaturated substituent such as an alkene group.
An example of a repeating unit of one such polymer is shown below:
Main chain or side chain liquid crystal polymers may also be made using the compounds of the present invention or metal-metal linked liquid crystal polymers. We have synthesised unsymmetrical chlorphyrins, i.e. , with one type of arylethynyl moiety in the 5- and 15-meso-positions and a different arylethynyl moiety in the 10- and 20-positions. Examples are shown below (where Z'" = alkyl):
By judicious use of 5,15-ethynyl substituents with protecting groups (e.g. Me3Si-), we can produce porphyrins with two bare acetylenes. These can be polymerised or copolymerised (e.g.. with poly(phenylene vinylene)) to make electroluminescent polymers. Alternatively, the bare acetylenic substituents may be reacted individually with electron donor and acceptor groups to furnish "push-pull" acetylenic porphyrins with large 1st-order hyperpolarisabilities.
Langmuir Blodgett Films incorporating compounds of the present invention may be used as optical or thermally addressable storage media.
The compounds of the present invention may also be used as molecular wires, see R.J.M. Nolte at al, Angew. Chem. Int. Ed. Eng., 1994, 33(21), 2173.
Water soluble paramagnetic manganese complexes of the porphyrins of the present invention, including Mn(III) porphyrins, may be used in methods for enhancing images obtained from magnetic resonance imaging of a region of regions containing a malignant tumour growth.
The compounds of the present invention may be used as photodynamic therapeutic (PDT) agents. The combination of a sensitiser and electromagnetic radiation for the treatment of cancer is commonly known as photodynamic therapy. In the
photodynamic therapy of cancer, dye compounds are administered to a tumour-bearing subject, these dye substances may be taken up, to a certain extent by the tumour. Upon selective irradiation with an appropriate light source (e.g. a laser) the tumour tissue is destroyed via the dye mediated photo-generation of a species such as singlet oxygen or other cytotoxic species such as free radicals, for example hydroxy or superoxide. This requires the sensitiser to have a high triplet yield and lifetime in order to have the best chance of sensitising singlet oxygen production. It also requires a source of laser illumination into the tumour, the cheapest and most penetrating laser light being red.
Porphyrins absorb strongly in the blue, which means they are not well "tuned" to work with red light and so their PDT effect is not very penetrating. Thus macrocycles with intense, longer- wave absorptions (e.g., chlorins, phthalocyanines,
benzporphyrins, etc.), are increasingly being tested as PDT sensitisers. Chlorphyrins have better red-light absorbing properties than porphyrins, and would be well-suited for PDT. Further, chlorphyrins showing excellent triplet-state yields and lifetimes.
PCT/GB94/01847 describes substituted metallophthalocyanines and phthalocyanines as PDT agents. Many of the techniques described therein (and references cited) are applicable to the current materials.
Metalloporphyrins, particularly the Pt and Pd complexes, have been used in phosphoimmunoassays (PLA) [AP Savitsby et al, Dokl. Acad. Nauk SSSR, 1989, 304, 1005]. Also the extreme sensitivity of these metalloporphyrins' triplet excited states to dissolved oxygen has been used to measure dissolved O2 levels in biological systems
[TJ Green et al, Anal. Biochem. , 1988, 174, 73; EP 0 127 797A and US-A- 4,707,454]. Because porphyrins subsituted with four mwøarylethynyl groups have very high triplet yields, we envisage they will have improved characteristics of PLA and/or sensitivity to dissolved O2.
In one preferred embodiment the compound of Formula contains at least one crown-ether. A preferred example is shown below:
It is believed that chlorphyrins with aryl crown-ether substituents will complex suitable metal cations. This will be efficiently 'communicated' to the macrocycle, via the acetylenic groups. Such a substituted chlorphyrin will experience significant alteration of the absorption and/or emission properties. Alternatively, NLO-active unsymmetrical chlorphyrins with two crown-ether substituents may change their NLO properties on metal complexation. Thus, crown-ether-substituted chlorphyrins could act as sensors for low concentrations of metals.
Various further preferred features and embodiments of the present invention will now be described by way of non-limiting example with reference to the following
Examples and drawings, in which: Figures 1, 2, 3, 4 and 5 show synthetic schemes for compounds in accordance with embodiments of the present invention: and
Figure 6 illustrates a liquid crystal device in which the materials of the current invention may be incorporated.
Reagents and conditions used in the synthetic routes of Figures 1 and 2 are as follows: i) BuLi/THF/-78°C
ii) DMF /room temperature
iii) H+/Η2O
iv) C9H19Br/K2CO3/DMF/70-80°C
v) Zn/(C6H5)3P/CBr4/DCM
Reagents and conditions used in the synthetic route of Figure 4 are as follows:
i) Pyrrole (large excess), BF3.OEt2, -25ºC, 15 minutes - 1 hour
ii) BF3.OEt2, CH2Cl2, -25°C
Butyllithium was ordered as a 1.6 molar solution in THF from Aldrich Chemical Co.,
The Old Brickyard, New Road, Gillingham Dorset, U.K..
DMF = dimethylformamide,
THF = tetrahydrofuran,
K2CO3 = anhydrous potassium carbonate,
4-octylphenylacetylene was obtained from Maybridge Chemical Company Ltd,
Trevillett, Tintagel. Comwell, U.K.
All other chemicals were obtained from Aldrich.
Preparations
4-Octylphenylpropynal 3: see Figure 1 for synthesis from 4-octylphenylacetylene. Yield = 0.85g (84%). IR (neat thin film); 2200 (-C≡C- stretch), 1600 (unsaturated - C=O stretch) cm-1 : Mass spec, m/e required M+ = 242; found M+ = 242; [M-CO]+ = 214; [M-C4H9]+ = 185; [M-CO-C4H9] = 157. Ηnmr, H(CDCl3): 9.41 (s, 1H, -CHO), 7.37 (q, 4H, centre of aryl AB spin system, JAB = 7.9Hz), 2.64 (t, 2H, -CH2- next to aryl ring), 1.61 (m, 2H, -CH2- flanked by two others in octyl chain), 1.26 (m, 12H, rest of octyl chain), 0.88 (t, -CH3, terminal methyl in octyl chain) ppm. 4-Octylphenylpropynal 3 was prepared from 4-octylphenylactetylene by quenching the acetylide (formed by low temperature reaction with BuLi. see Brandsma in "Preparative Acetylene Chemistry" 2nd Edition, Studies in Organic Chemistry 34, Elsevier Science Publishers (Amsterdam), 1998, Chapter 2, pl3) with DMF, followed by acid hydrolysis. Lindsey porphyrin synthesis (Lindsey and Lee in tetrahedron, 1994, 50, 11427) with pyrrole gave porphyrin 2b in 8% yield and a small amount of a second porphyrin-like product that eluted more slowly from a silica column with dichloromethane (DCM).
4-Nonyloxyphenylpropynal 5: see Figure 2 for synthesis from 4- hydroxybenzaldehyde. Yield = 1.54g (91%, from preceding 4). IR (neat thin film); 2190 (-C≡C- stretch), 1660 (unsaturated -C=O stretch) cm-1 : Mass spec, m/e required M+ = 272; found M+ = 272; [M-C9H18]+ = 146; [M-C9H18-CO]+ = 1 18; Ηnmr, H(CDCl3): 9.39; (s, 1H, -CHO), 7.22 (q, 4H, centre of aryl AB spin system, JAB = 8.5Hz), 3.99 (t, 2H, -CH2- next to oxygen on aryl ring), 1.79 (p, 2H, -CH2- flanked by two others in nonyi chain near oxygen), 1.46 (p, 10H, rest of nonyl chain), (t, -CH3, terminal methyl in nonyl chain) ppm.
4-Nonyloxyphenylpropanal 5 was prepared in a three-step synthesis from 4- hydroxybenzaidehyde. Alkylation of the phenolic -OH with 1 -bromononane was followed by a Corey and Fuchs reaction with CBr4, triphenylphosphine and zinc (see Tetrahedron Lett.. 1972, 3769) to give β,β-dibromostyryl derivative 4. Low temperature reaction of 4 with 2.5 equivalents of BuLi followed by quenching of the
acetylide with DMF and acid hydrolysis yielded 5 Care was taken not to allow the acidity of this reaction to drop below pH 6-7 otherwise no arylpropynal was produced
(see Brandsma ibid Chapter 4, p102). Lindsey porphyrin synthesis with pyrrole and
4, using BF3.OEt2 as catalyst, afforded porphyrin 2c in 3% yield. A second porphyrin- like product was separated as the major product via column chromatography on silica gel, eluting with DCM.
Examples
The synthesis of compounds in Figure 4 was carried out based on methods described earlier in this application and of Lindsey, apart from the reactions were carried out at - 25°C as opposed to room temperature (as in Lindsey). All of the flieso-substituted dipyrromethanes were isolated in the pure form by chromatography [silica gel.
cyclohexane/ethyl acetate/triethylamine 80:20:1]. All of the porphyrins were isolated as green solids after column chromatography.
Metallations were carried out according to standard procedures, for example see J.W. Buchler in "The Porphyrins" Ed. D. Dolphin, Academic Press, New York, 1978, 1, p390. 5, 10, 15,20-Mesotetra(4-octylphenylethynyl)porphyrin 2b: boron trifluoride dietherate (40μl, 0.33mM) was added to a stirred, nitrogen degassed solution of 4-octylphenylpropynal (0.61g, 2.5mM) pyrrole (0.17g, 2.5mM) in dry, distilled DCM (250ml) at-25°C. The reaction mixture was kept at this temperature during 4 hours, then allowed to warm to room temperature overnight. 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) (570mg, 2.5mM) was then added, resulting in the reaction solution turning green. The solvent was removed under vacuum, and the residue purified by column chromatography (silica gel; DCM) to give a dark green sticky solid. Trituration with methanol and filtration gave the desired porphyrin as a dark green powder 58mg (8%), melting point = 171-172°C (with decomposition): IR (nujol mull); 2196cm-1, weak: H(CDCl3); 9.27 (s, 8H, β-pyrrole-H), 7.67 (q, 16H, centre of aryl AB spin-system, JAB = 7.9Hz), 2.78 (t, 8H, -CH2- next to aryl ring), 1.78 (p, 8H, -CH2- flanked by two methylene groups), 1.55-0.88 (m, 52H, rest of octyl
chain).FABMS, [M+] found 1 158.7512; C84H94N4 requires [M+] = 1 158.7512. A second minor porphyrin-like fraction was isolated from the column as a green powder. Yield = 5.2mg. 5,10,15,10-Mesotetra(4-nony loxyphenylethynyl)porphyrin 2c: the synthetic procedure for this porphyrin was the same as for 2b using identical molar quantities of boron trifluoride dietherate (40μl, 0.33mM), 4-nonyloxyphenylpropynal (0.68g, 2.5mM), pyrrole (0.17g, 2.5mM), DDQ (570mg, 2.5mM) and DCM (250ml). Trituration of the dark green oil initially obtained after column chromatography on silica with methanol yielded 2c as a green powder. Yield = 19(3%), melting point = 147-148°C; IR (nujol mull); 2192cm-1: H(CDCl3); 9.1 1 (s, 8H, β-pyrrole-H), 7.48 (q, 16H, centre of aryl AB spin-system, JAB = 8.2Hz), 4.08 (t, 8H, -CH2- next to aryl ring), 1.91 (p, 8H, -CH2- flanked by two methylene groups), 1.55-0.84 (m, 60H, rest of nonyl chain), -3.00 (s, 2H, N-H).FABMS, [M+] found 1278.7512; C88H102N4 requires [M+] = 1278.7512. A second minor porphyrin-like fraction was isolated from the column as a green powder. Yield = 33mg.
Alkynyl meso substituents significantly red-shift the porphyrin B and Q bands (see Anderson, Tetrahedron Lett., 1992, 33, 1 101). Thus, compared to
mesotetraphenylporphyrin (TPP), the B band of porphyrin 1 (shown below) is red-shifted by about 34nm. Replacing the trimethylsilyl group of 1 with an aryl group increases the B and Q band red shifts even further (46 {2a}, 54 {2b}, and 57 {2c} nm for the B band). In addition, there is a marked increase in the main Q band absorption relative to that of the B band, and two of the Q bands appear as smaller shoulders either side of the main Q band absorption. This illustrates that the ethynyl groups mediate communication between the porphyrin and aryl pi-systems more effectively than when the aryl group is connected directly to the porphyrin macromolecule. We have also found that substituents on the aryl group can affect the red-shift. For example in terms of red-shift alkoxy>alkyl>H. We have also found that a bigger increase in red-shifts occurs in trans-disubstituted substituted compounds compared to tetrasubstituted substituted compounds.
Details of compound 1 may be found in Anderson ibid.
Solid samples and DCM solutions of the neutral porphyrins 2b and 2c are green. Acidification with several drops of trifluoroacetic acid turns solutions of 2b mustard yellow and solution of 2c pink. The second porphyrin-Iike compounds obtained as by-products would appear from a combination of FAB mass spectroscopy (same m/e values as 2b and 2c) and 1HHmr (which shows separate doublets for each of the β-protons - a pattern not consistent with one or two different meso-substituents - see Milgrom et al, Tetrahedron, 1989, 45, 7431 and Milgrom, J. Chem. Soc, Perkin Trans. 1., 1984, 1483); also the presence of separated peaks at higher field than TMS, i.e. two different protons inside the macrocycle suggest these porphyrin-like by-products may be isomers of 2b and 2c - containing 2-aza-21 -carbaporphyrin macrocycle as described by Chmielewskj at al, Chem. Eur. J., 1995, 1, 68.
Other compounds of general Formula I may be prepared by corresponding methods to those described above. For example, trans-disubstituted meso-tetraethynylporphyrins in accordance with the present invention may be prepared by coupling acetylenic dipyrromethanes with substituted propynals. In general the synthesis involves reaction of arylethynyl dipyrromethanes with a variety of propynals. Thus arylethynyl dipyrromethanes were prepared in high yield via Lindsey' s procedure. Chlorphyrins were synthesised by condensation of propynals prepared using literature methods with arylethynyl dipyrromethanes at -25ºC in the presence of BF3.OEt2 as catalyst. DDQ oxidation of the resulting porphyrinogens gave high yields of chlorphyrins.
Interestingly, no by-products of this synthesis were observed.
A preferred variation on this process involves protection of the acteylene moiety in the acetylene-aldehyde precursor with dicobaltoctacarbonyl. Following the preparation of the porphyrin. either by one-pot Lindsey synthesis or via the dipyrromethane, the protecting group is photochemically removed to afford the mejotetraarylethynylporphyrin in much improved yield.
Further examples of compounds in accordance with the present invention where A is phenyl are given below in Tables I and II; although A could just as easily be for example pyridine, pyrrole, pyrazine, imidazole, furan or thiophene.
An example of the use of a material and device embodying the present invention will now be described with reference to Figure 6.
The Liquid crystal device consists of two transparent plates, 1 and 2, for example made from glass. These plates are coated on their internal face with transparent conducting electrodes 3 and 4. An alignment layer is introduced onto the internal faces of the cell so that a planar orientation of the molecules making up the liquid crystalline material will be approximately parallel to the glass plates 1 and 2. This is done by coating the glass plates 1,2 complete with conducting electrodes 3,4 with layers of film 5 and 6 of a suitable polymer, e.g. polyimide. The electrodes 3,4 may be formed into row and column electrodes so that the intersections between each column and row form an x,y matrix of addressable elements or pixels. Prior to the construction of the cell the films 5,6 are rubbed with a roller covered in cloth (for example made from velvet) in a given direction, the rubbing directions being arranged parallel (same or opposite direction) upon construction of the cell. A spacer 7, e.g. of polymethyl methacrylate, separates the glass plates 1,2 to a suitable distance, e.g. 2 microns. Liquid crystal material 8 is introduced between glass plates 1,2 by filling the space in between them. This may be done by flow filling the cell using the standard techniques. The spacer 7 is sealed with an adhesive 9 in a vacuum using an existing technique. Polarisers 10, 11 may be arranged in front of and behind the cell.
Alignment layers may be introduced onto one or more cell walls by one or more of the standard surface treatment techniques such as rubbing, oblique evaporation or as described above by the use of polymer aligning layers.
The device may operate in a transmissive or reflective mode. In the former, light passing through the device, e.g. from a tungsten bulb, is selectively transmitted or blocked to form the desired display. In the reflective mode a mirror, or diffuse reflector 12 is placed behind the second polariser 11 to reflect ambient light back through the cell and two polarisers. By making the mirror partly reflecting the device may be operated both in a transmissive and reflective mode. In an alternative embodiment a single polariser and dye material may be combined.
Claims
1. A compound of general Formula I:
wherein R1, R2, R3 and R4 are each independently H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl)3, halogen, CHO, COOR5, OH, CN, NO2, NO, NR5R6 or the following Formula II:
is optionally subsituted aryl or optionally subsituted heteroaryl;
R5 and R6 are each independently hydrogen, optionally subsituted alkyl, optionally substituted alkenyl, optionally substituted aryl, halogen or hydroxy;
X, Y, X1, Y2 and Z are each independendy H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl)3, halogen, CHO, COOR5, OH, CN, NO2, NO, NR5R6, any adjacent two groups taken together form a -(OCH2CH2)n- group wherein n is 1 , 2 or 3, or the following Formula III:
wherein J is a single bond,≡ , CH2O, OCH2, COO, OOC, NHCO, CONH, CH2 or O;
Q is H, optionally substituted alkyl, optionally substituted alkoxy, optionally subsituted alkenyl, optionally subsituted alkenyloxy, Si(alkyl)3, halogen, CHO, COOR5, OH, CN, NO2, NO, NR5R6; is optionally substituted aryl or optionally subsituted heteroaryl;
provided that at least one of R1, R2, R3 or R4 is selected from Formula II;
M is 2H with each of the two nitrogen atoms indicated being bonded to a single hydrogen, or M is a metal atom, metal compound or silicon or a compound of silicon.
2. A compound according to claim 1 wherein R1, R2, R3 and R4 are each independently H, C1-20 alkyl, halogen, CHO, OH or the group of Formula II. wherein A is phenyl; Z is selected from H, C1-20 alkyl or alkoxy, CN, NO2, NO, N(C1-20 alkyl)2; X1 and Y2 are independently selected from H, halogen, C1-20 alkyl or alkoxy, C1-20 haloalkane;
X and Y are each independently chosen from H, halogen, C1-20 alkyl or alkoxy or a group of Formula III, wherein J is as defined in claim 1 , Q is H, C1-20 alkyl or alkoxy, CN halogen, NO2, NO, N(C1-20 alkyl)2; B is phenyl and, in addition to H, may be substituted with at least one of the following groups: halogen, C1-20 alkyl or alkoxy.
3. A compound according to claim 1 or claim 2 wherein the metal atom is Ni, Pb, V, Pd, Co, Nb, Al, Sn, Zn, Cu, Mg, Ca, In, Ga, Fe, Eu, Lu, Pt, Ru, Mn or Ge.
4. A compound according to any preceding claim wherein R1, R2, R3 and R4 are all a group of Formula II.
5. A compound according to any one of claims 1 to 3 wherein R1 and R3 are a group of Formula II and R2 and R4 are each independently another group or R2 and R4 are a group of Formula II and R1 and R3 are each independently another group.
6. A compound according to any preceding claim wherein M is 2H or Zn.
7. A compound according to any preceding claim wherein any one of X, Z or Y is C1-20 alkyl or alkoxy.
8. A compound according to any one of claims 1 to 6 wherein X and Z or Y and Z together form a -(OCH2CH2)n- group.
9. A polymer derivable from the polymerisation of a compound of any one of claims 1 to 8.
10. A composition comprising at least one of the compounds of any one of claims 1 to 9.
11. A liquid crystal device comprising a compound of any one of claims 1 to 9 or a composition of claim 10.
12. A reverse saturable absorber comprising a compound of any one of claims 1 to 9 or a composition of claim 10.
13. A photodynamic therapy agent comprising a compound of any one of claims 1 to 9 or a composition of claim 10.
14. A biaxial nematic device comprising a compound of any one of claims 1 to 9 or a composition of claim 10.
15. An optical storage medium comprising a compound of any one of claims 1 to
9 or a composition of claim 10.
16. A optical recording medium comprising a compound of any one of claims 1 to 9 or a composition of claim 10.
17. A device comprising two spaced cell walls each bearing electrode structures and treated on at least one facing surface with an alignment layer, a layer of a liquid crystal material enclosed between the cell walls, characterised in that the liquid crystal material comprises a compound of any one of claims 1 to 9 or a composition of claim 10.
18. A process for preparing the compound of any one of claims 1 to 9 comprising reacting at least one intermediate of Formula IV IV R' - W where R' is at least one of R1, R2, R3 or R4 with pyrrole.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU76348/96A AU7634896A (en) | 1995-11-23 | 1996-11-22 | Substituted porphyrins |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9524028.9 | 1995-11-23 | ||
| GB9524028A GB9524028D0 (en) | 1995-11-23 | 1995-11-23 | Substituted porphyrins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1997020846A1 true WO1997020846A1 (en) | 1997-06-12 |
Family
ID=10784382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB1996/002899 Ceased WO1997020846A1 (en) | 1995-11-23 | 1996-11-22 | Substituted porphyrins |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7634896A (en) |
| GB (1) | GB9524028D0 (en) |
| WO (1) | WO1997020846A1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999050269A3 (en) * | 1998-03-31 | 1999-11-18 | Schastak Astrid | Porphyrins and their use as photosensitizer |
| EP1063236A1 (en) * | 1999-06-07 | 2000-12-27 | Agency of Industrial Science and Technology of Ministry of International Trade and Industry | Photoconducting silicon complexes, liquid crystal materials, composition thereof, and elements using same |
| US6630128B1 (en) | 1998-08-28 | 2003-10-07 | Destiny Pharma Limited | Porphyrin derivatives their use in photodynamic therapy and medical devices containing them |
| WO2004046151A3 (en) * | 2002-11-21 | 2004-08-12 | Photobiotics Ltd | Porphyrin derivatives |
| WO2004076461A1 (en) * | 2003-02-26 | 2004-09-10 | Photobiotics Limited | Porphyrin derivatives |
| US6869479B2 (en) * | 2002-03-29 | 2005-03-22 | Altair Center, Llc | Method of laser-assisted fabrication of optoelectronic and photonic components |
| WO2005000854A3 (en) * | 2003-06-06 | 2005-05-12 | Eukarion Inc | Orally bioavailable low molecular weight metalloporphyrins as antioxidants |
| US6906050B2 (en) | 2001-05-31 | 2005-06-14 | Miravant Pharmaceuticals, Inc. | Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis |
| US6953570B2 (en) | 2001-08-22 | 2005-10-11 | Montana State University | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| WO2007081490A1 (en) * | 2006-01-04 | 2007-07-19 | Kent State University | Light-harvesting discotic liquid crystalline porphyrins and metal complexes |
| WO2007081505A3 (en) * | 2006-01-04 | 2007-08-30 | Univ Kent State Ohio | Nanoscale discotic liquid crystalline porphyrins |
| CN102408745A (en) * | 2011-11-25 | 2012-04-11 | 北京科技大学 | A class of asymmetric dye molecules with tetraphenylporphyrin as the core and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252698A (en) * | 1992-10-09 | 1993-10-12 | Sri International | Metal ion porphyrin-containing poly(azine) |
-
1995
- 1995-11-23 GB GB9524028A patent/GB9524028D0/en active Pending
-
1996
- 1996-11-22 AU AU76348/96A patent/AU7634896A/en not_active Abandoned
- 1996-11-22 WO PCT/GB1996/002899 patent/WO1997020846A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252698A (en) * | 1992-10-09 | 1993-10-12 | Sri International | Metal ion porphyrin-containing poly(azine) |
Non-Patent Citations (3)
| Title |
|---|
| G. PROESS ET AL.: "Synthesis of meso-tetraalkyl porphyrins using 1-seleno-2-alkynyl cation precursors", TETRAHEDRON LETTERS, vol. 33, no. 2, 1992, OXFORD GB, pages 269 - 272, XP002030190 * |
| L.R. MILGROM ET AL.: "5,10,15,20-meso- Tetraarylethynylporphyrins", TETRAHEDRON LETTERS, vol. 36, no. 49, 1995, OXFORD GB, pages 9061 - 9064, XP002030191 * |
| L.R. MILGROM ET AL.: "Trans-disubstituted meso-tetraethynylporphyrins", TETRAHEDRON LETTERS, vol. 37, no. 23, 1996, OXFORD GB, pages 4069 - 4072, XP002030192 * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410568B1 (en) | 1998-03-31 | 2002-06-25 | Astrid Schastak | Porphyrins and their use as photosensitizer |
| WO1999050269A3 (en) * | 1998-03-31 | 1999-11-18 | Schastak Astrid | Porphyrins and their use as photosensitizer |
| US6630128B1 (en) | 1998-08-28 | 2003-10-07 | Destiny Pharma Limited | Porphyrin derivatives their use in photodynamic therapy and medical devices containing them |
| EP1063236A1 (en) * | 1999-06-07 | 2000-12-27 | Agency of Industrial Science and Technology of Ministry of International Trade and Industry | Photoconducting silicon complexes, liquid crystal materials, composition thereof, and elements using same |
| US6906050B2 (en) | 2001-05-31 | 2005-06-14 | Miravant Pharmaceuticals, Inc. | Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis |
| US6953570B2 (en) | 2001-08-22 | 2005-10-11 | Montana State University | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| US6869479B2 (en) * | 2002-03-29 | 2005-03-22 | Altair Center, Llc | Method of laser-assisted fabrication of optoelectronic and photonic components |
| WO2004046151A3 (en) * | 2002-11-21 | 2004-08-12 | Photobiotics Ltd | Porphyrin derivatives |
| WO2004076461A1 (en) * | 2003-02-26 | 2004-09-10 | Photobiotics Limited | Porphyrin derivatives |
| WO2005000854A3 (en) * | 2003-06-06 | 2005-05-12 | Eukarion Inc | Orally bioavailable low molecular weight metalloporphyrins as antioxidants |
| US7649091B2 (en) | 2003-06-06 | 2010-01-19 | Eukarion, Inc. | Orally bioavailable low molecular weight metalloporphyrins as antioxidants |
| WO2007081490A1 (en) * | 2006-01-04 | 2007-07-19 | Kent State University | Light-harvesting discotic liquid crystalline porphyrins and metal complexes |
| WO2007081505A3 (en) * | 2006-01-04 | 2007-08-30 | Univ Kent State Ohio | Nanoscale discotic liquid crystalline porphyrins |
| US7279570B2 (en) | 2006-01-04 | 2007-10-09 | Kent State University | Nanoscale discotic liquid crystalline porphyrins |
| US7291727B1 (en) | 2006-01-04 | 2007-11-06 | Kent State University | Light-harvesting discotic liquid crystalline porphyrins and metal complexes |
| CN102408745A (en) * | 2011-11-25 | 2012-04-11 | 北京科技大学 | A class of asymmetric dye molecules with tetraphenylporphyrin as the core and preparation method thereof |
| CN102408745B (en) * | 2011-11-25 | 2014-06-18 | 北京科技大学 | Asymmetrical dye molecule adopting tetraphenylporphin as core, and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AU7634896A (en) | 1997-06-27 |
| GB9524028D0 (en) | 1996-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chan et al. | Lanthanide–tetrapyrrole complexes: synthesis, redox chemistry, photophysical properties, and photonic applications | |
| Han et al. | Aggregation‐induced emission materials for nonlinear optics | |
| US10059843B2 (en) | Rhodamine derivatives dyes, color-conversion-layer and uses thereof | |
| US6384027B1 (en) | Phthalocyanine analogs | |
| Fuhrhop et al. | Micellar rods and vesicular tubules made of 14''', 16'''-diaminoporphyrins | |
| JP4643761B2 (en) | Novel cross-linked hexaarylbisimidazole compound and derivative thereof, method for producing the compound, and precursor compound used in the method | |
| Singh et al. | Monomeric and aggregation emissions of tetraphenylethene in a photo-switchable polymer controlled by cyclization of diarylethene and solvent conditions | |
| WO1997020846A1 (en) | Substituted porphyrins | |
| Lonshakov et al. | New fluorescent switches based on photochromic 2, 3-diarylcyclopent-2-en-1-ones and 6-ethoxy-3-methyl-1H-phenalen-1-one | |
| Çakır et al. | Water soluble peripheral and non-peripheral tetrasubstituted zinc phthalocyanines: Synthesis, photochemistry and bovine serum albumin binding behavior | |
| Miyatake et al. | Synthesis and self-assembly of amphiphilic zinc chlorins possessing a 31-hydroxy group | |
| Şahin et al. | Synthesis, photophysical and photochemical properties of a set of silicon phthalocyanines bearing anti-inflammatory groups | |
| US5792860A (en) | Substituted phthalocyanides with sulfonyl substituted with amino or carboxyl groups | |
| Thorat et al. | NIR-emitting Boradiazaindacene fluorophores-TD-DFT studies on electronic structure and Photophysical properties | |
| Jiao et al. | Soluble and stable near-infrared dyes based on polycyclic aromatics | |
| US5942612A (en) | Substituted phthalocyanine liquid crystal compounds | |
| WO2004046151A2 (en) | Porphyrin derivatives | |
| Sani et al. | Hybridising inorganic materials with fluorescent BOPHY dyes: A structural and optical comparative study | |
| Qian et al. | Synthesis and efficient three-photon excited green fluorescence of pyridine–triphenylamine conjugated dyes | |
| Karthaus et al. | Stilbene-containing amphiphiles in supramolecular assemblies | |
| Li et al. | Metal–Organic Dimerization of Dissymmetrical Ligands toward Customized Through-Space Chromophore Interactions | |
| Ozturk et al. | Synthesis and characterization of new Y-shaped fluorophores with an imidazole core | |
| CN109627267A (en) | Iridium complex, and synthesis method and application thereof | |
| US7449578B1 (en) | Two-photon absorbing materials with quenched emission | |
| Viljakka | SYNTHESIS AND CHARACTERIZATION OF INDIGO PHOTOSWITHES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97521055 Format of ref document f/p: F |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| 122 | Ep: pct application non-entry in european phase |